00911.HK
Qianhai Health Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.47
−4.08%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 836.2M | 677.1M | 519.7M | 961.3M | 2.0B |
| Cost of Revenue | 826.5M | 654.9M | 490.0M | 996.9M | 1.9B |
| Gross Profit | 9.7M | 22.3M | 29.7M | (35.6M) | 76.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 24.7M | 16.6M | 15.5M | 16.8M | 19.4M |
| General & Admin Expense | 28.5M | 13.9M | 15.3M | 16.6M | 19.2M |
| Selling & Marketing Expense | 363.0K | 169.0K | 185.0K | 142.0K | 166.0K |
| Other Expenses | 107.0K | — | 60.7M | 351.0K | 313.9M |
| Total Operating Expenses | 24.8M | 16.6M | 76.2M | 17.1M | 333.3M |
| Cost and Expenses | 851.4M | 671.5M | 505.8M | 1.0B | 2.1B |
| Operating Income (EBIT) | (15.2M) | 5.7M | 13.9M | (52.7M) | (163.9M) |
| Non-Operating | |||||
| Interest Income | 525.0K | 484.0K | 243.0K | 69.0K | 100.0K |
| Interest Expense | 52.0K | 38.0K | 23.0K | 43.0K | 34.0K |
| Net Interest Income | 475.5K | 446.0K | 220.0K | 26.0K | 66.0K |
| Other Non-Op Income/Expense | 7.4M | 275.0K | 47.8M | (1.5M) | (69.8M) |
| Non-Operating Income (excl Interest) | (18.8M) | 1.0M | (47.8M) | (43.0K) | 69.7M |
| EBT (Pre-Tax Income) | (7.8M) | 5.9M | 1.3M | (52.7M) | (233.7M) |
| Income Tax Expense | 53.0K | 2.0K | — | — | (22.0M) |
| Bottom Line | |||||
| Net Income | (7.8M) | 5.9M | 1.3M | (52.7M) | (233.7M) |
| Earnings from Cont. Ops | (7.8M) | 5.9M | 1.3M | (52.7M) | (233.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (7.8M) | 5.9M | 1.3M | (52.7M) | (233.7M) |
| Per Share | |||||
| Basic EPS | (HK$0.05) | HK$0.04 | HK$0.01 | (HK$0.03) | (HK$1.38) |
| Diluted EPS | (HK$0.05) | HK$0.04 | HK$0.01 | (HK$0.03) | (HK$1.38) |
| Revenue Per Share | HK$4.93 | HK$4.00 | HK$3.07 | HK$0.57 | HK$11.58 |
| Shares | |||||
| Basic Shares Outstanding | 169.4M | 169.4M | 169.4M | 1.7B | 169.4M |
| Diluted Shares Outstanding | 169.4M | 169.4M | 169.4M | 1.7B | 169.4M |
| Profitability Metrics | |||||
| EBITDA | 7.3M | 7.4M | 15.6M | (50.2M) | (231.2M) |
| D&A | 2.6M | 1.7M | 1.7M | 2.4M | 2.4M |
| EBIT | 4.7M | 5.7M | 13.9M | (52.7M) | (233.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026